Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
This will be an open-label, non-randomized multi-center study designed to assess the safety
and efficacy of Adipose-derived Stem Cell (ASC) IV implantation. The therapy is composed of
cells isolated from a patient's own adipose tissue. Liposuction will be performed to collect
the adipose tissue specimen for subsequent processing to isolate the stem cells.